Sarah Moran

1.5k total citations
37 papers, 910 citations indexed

About

Sarah Moran is a scholar working on Nephrology, Pulmonary and Respiratory Medicine and Genetics. According to data from OpenAlex, Sarah Moran has authored 37 papers receiving a total of 910 indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Nephrology, 13 papers in Pulmonary and Respiratory Medicine and 11 papers in Genetics. Recurrent topics in Sarah Moran's work include Renal Diseases and Glomerulopathies (13 papers), Vasculitis and related conditions (11 papers) and Complement system in diseases (5 papers). Sarah Moran is often cited by papers focused on Renal Diseases and Glomerulopathies (13 papers), Vasculitis and related conditions (11 papers) and Complement system in diseases (5 papers). Sarah Moran collaborates with scholars based in Ireland, United Kingdom and United States. Sarah Moran's co-authors include Françoise Cluzeau, Gene Feder, Jeremy Grimshaw, Peter Littlejohns, Michael G Molloy, Sinéad Kinsella, Joseph A. Eustace, Mark A. Little, Rob Bale and Peter Littlejohns and has published in prestigious journals such as New England Journal of Medicine, SHILAP Revista de lepidopterología and Kidney International.

In The Last Decade

Sarah Moran

30 papers receiving 879 citations

Peers

Sarah Moran
Aisling E. Courtney United Kingdom
Avinainder Singh United States
G. Pugnet France
John Anthony South Africa
Aisling E. Courtney United Kingdom
Sarah Moran
Citations per year, relative to Sarah Moran Sarah Moran (= 1×) peers Aisling E. Courtney

Countries citing papers authored by Sarah Moran

Since Specialization
Citations

This map shows the geographic impact of Sarah Moran's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sarah Moran with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sarah Moran more than expected).

Fields of papers citing papers by Sarah Moran

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sarah Moran. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sarah Moran. The network helps show where Sarah Moran may publish in the future.

Co-authorship network of co-authors of Sarah Moran

This figure shows the co-authorship network connecting the top 25 collaborators of Sarah Moran. A scholar is included among the top collaborators of Sarah Moran based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sarah Moran. Sarah Moran is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Murt, Ahmet, İlay Berke, Annette Bruchfeld, et al.. (2025). Malignancies and glomerulonephritis: when to suspect and when to screen?. Clinical Kidney Journal. 18(5). sfaf101–sfaf101. 2 indexed citations
2.
Teng, Y K Onno, Eleni Frangou, Andreas Kronbichler, et al.. (2025). Disease-modifying anti-nephropathic drugs (DMANDs)—a definition proposed by the Immunonephrology Working Group (IWG) of the European Renal Association (ERA). Nephrology Dialysis Transplantation. 40(6). 1243–1247.
3.
Morelle, Johann, Fernando Caravaca‐Fontán, Fádi Fakhouri, et al.. (2025). Complement activation in secondary thrombotic microangiopathies. Nephrology Dialysis Transplantation. 40(11). 2193–2206.
4.
Scott, Jennifer, Arthur White, Cathal Walsh, et al.. (2024). Computable phenotype for real-world, data-driven retrospective identification of relapse in ANCA-associated vasculitis. RMD Open. 10(2). e003962–e003962.
5.
Steiger, Stefanie, Li Li, Annette Bruchfeld, et al.. (2024). Sex dimorphism in kidney health and disease: mechanistic insights and clinical implication. Kidney International. 107(1). 51–67. 5 indexed citations
6.
Bruchfeld, Annette, Fernando Caravaca‐Fontán, Gema Fernández‐Juárez, et al.. (2024). Immunoengineering for autoimmune-kidney disease. Nephrology Dialysis Transplantation. 39(12). 1934–1937. 1 indexed citations
7.
Berke, İlay, Ingeborg M. Bajema, Annette Bruchfeld, et al.. (2024). Management of adult patients with podocytopathies: an update from the ERA Immunonephrology Working Group. Nephrology Dialysis Transplantation. 39(4). 569–580. 14 indexed citations
8.
Scott, Jennifer, Arthur White, Cathal Walsh, et al.. (2023). #4553 REAL WORLD DATA-DRIVEN IDENTIFICATION OF ANCA VASCULITIS RELAPSE. Nephrology Dialysis Transplantation. 38(Supplement_1). 1 indexed citations
9.
Frangou, Eleni, Annette Bruchfeld, Gema Fernández‐Juárez, et al.. (2023). EULAR 2023 recommendations for SLE treatment: synopsis for the management of lupus nephritis: the European Renal Association–Immunonephrology Working Group (ERA-IWG) perspective. Nephrology Dialysis Transplantation. 39(5). 727–730. 3 indexed citations
10.
Frangou, Eleni, Annette Bruchfeld, Gema Fernández‐Juárez, et al.. (2023). EULAR 2023 recommendations for SLE treatment: synopsis for the management of lupus nephritis— the European Renal Association (ERA) — Immunonephrology Working Group (ERA-IWG) perspective. SHILAP Revista de lepidopterología. 12(4). 175–175.
11.
Vlasschaert, Caitlyn, Amy J. M. McNaughton, Michael Chong, et al.. (2022). Association of Clonal Hematopoiesis of Indeterminate Potential with Worse Kidney Function and Anemia in Two Cohorts of Patients with Advanced Chronic Kidney Disease. Journal of the American Society of Nephrology. 33(5). 985–995. 61 indexed citations
12.
White, Arthur, Cathal Walsh, Louis J. M. Aslett, et al.. (2022). Extended data for 'ANCA-associated vasculitis in Ireland: a multi-centre national cohort study'. Zenodo (CERN European Organization for Nuclear Research).
13.
Moran, Sarah, Jennifer Scott, Michael R. Clarkson, et al.. (2021). The Clinical Application of Urine Soluble CD163 in ANCA-Associated Vasculitis. Journal of the American Society of Nephrology. 32(11). 2920–2932. 25 indexed citations
14.
Pepper, Ruth J., Stephen P. McAdoo, Sarah Moran, et al.. (2018). A novel glucocorticoid-free maintenance regimen for anti-neutrophil cytoplasm antibody–associated vasculitis. Lara D. Veeken. 58(2). 1119–1119. 58 indexed citations
15.
Moran, Sarah, Paul A. Monach, Lina Zgaga, et al.. (2018). Urinary soluble CD163 and monocyte chemoattractant protein-1 in the identification of subtle renal flare in anti-neutrophil cytoplasmic antibody-associated vasculitis. Nephrology Dialysis Transplantation. 35(2). 283–291. 47 indexed citations
16.
McElnea, Elizabeth, et al.. (2017). Fungal keratitis in the Republic of Ireland. Eye. 31(10). 1427–1434. 21 indexed citations
17.
Oomatia, Amin, Sarah Moran, Claire Kennedy, et al.. (2016). Prolonged Duration of Renal Recovery Following ANCA-Associated Glomerulonephritis. American Journal of Nephrology. 43(2). 112–119. 7 indexed citations
18.
Moran, Sarah, et al.. (2011). Warfarin anticoagulation: a survey of patients’ knowledge of their treatment. Irish Journal of Medical Science (1971 -). 180(4). 819–822. 9 indexed citations
19.
Yamada, Kazuhiko, Atsushi Hirakata, Vaja Tchipashvili, et al.. (2011). Composite Islet-Kidneys From Single Baboon Donors Cure Diabetes Across Fully Allogenic Barriers. American Journal of Transplantation. 11(12). 2603–2612. 12 indexed citations
20.
Littlejohns, Peter, Françoise Cluzeau, Rob Bale, et al.. (1999). The quantity and quality of clinical practice guidelines for the management of depression in primary care in the UK.. PubMed. 49(440). 205–10. 54 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026